Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $256000.0.

  • Anaptysbio's Other Non-Current Assets changed 0.0% to $256000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $256000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $256000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Anaptysbio reported Other Non-Current Assets of $256000.0 as of Q3 2025, which was down 0.0% from $256000.0 recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Other Non-Current Assets ranged from a high of $477000.0 in Q1 2021 and a low of $256000.0 during Q4 2021
  • Its 5-year average for Other Non-Current Assets is $267842.1, with a median of $256000.0 in 2021.
  • In the last 5 years, Anaptysbio's Other Non-Current Assets tumbled by 8094.53% in 2021 and then changed by 0.0% in 2022.
  • Over the past 5 years, Anaptysbio's Other Non-Current Assets (Quarter) stood at $256000.0 in 2021, then changed by 0.0% to $256000.0 in 2022, then changed by 0.0% to $256000.0 in 2023, then changed by 0.0% to $256000.0 in 2024, then changed by 0.0% to $256000.0 in 2025.
  • Its Other Non-Current Assets was $256000.0 in Q3 2025, compared to $256000.0 in Q2 2025 and $256000.0 in Q1 2025.